Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[Nomo123]

All of these theories about how Anatabine works are fine.

But in the end customers overall aren't buying this product.

And the studies are far from impressive.

I've already posted why I think the studies aren't positives for the stock.

And if I were wrong, people much smarter than me would be buying this stock like crazy at a mere $1.29.

But they are not.

They likely realize that STSI is far from demonstrating any breakthrough and possibly never will prove ABloc works for the masses. And if something impressive really did come from one of these studies, they could always buy it then at possibly much lower prices.

This stock to me is one of the worst buy and hold candidates in the market with poor revenues and no clear leadership and no sign of things changing anytime soon.

A year ago I posted essentially the same thing on IV.